Pharmafile Logo
T40 2022 Cover
Diversity, Equity and Inclusion
Communiqué 53 Cover Image
- PMLiVE

XDx

- PMLiVE

Ian Dalton leaves NHS to lead health services at BT

Follows departure of Jim Easton to private health firm

- PMLiVE

EC to investigate Novartis and J&J in antitrust probe

Claims companies agreed to delay entry of generic painkiller

Bedrock hires new client services director

Patricia Forsyth joins from Acumed

- PMLiVE

Anker Lundemose appointed CEO of Bionor Pharma

Will lead efforts to develop and commercialise HIV vaccines

Questcor appoints SVP corporate strategic development

Michael Aldridge joins from Australian early development company Xenome

- PMLiVE

Draftfcb New York announces internal re-shuffle

Dana Maiman to focus on Draftfcb Healthcare as agency steps up its healthcare offering

- PMLiVE

Kantar Health appoints two senior researchers

Dr Theano Anasta and Svetlana Gogolina join research firm

- PMLiVE

GSK appoints Heineken and Shell director Hans Wijers to board

Is also chair designate of the brewery firm

Novartis building

Novartis withdraws application for Ruvise approval in EU

Had submitted imatinib mesylate for use in hypertension

- PMLiVE

Portland appoints lead for new health communications practice

Louise Fish is currently director of communications at the NHS Confederation

- PMLiVE

NICE backs two cystic fibrosis treatments for NHS use

Novartis’ Tobi Podhaler and Forest’s Colobreathe recommended at discounted price

Novartis building

Novartis expects tough 2013 before a return to growth

Says it will take a year for new medicine sales to overcome Diovan patent loss

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links